Laia Agell
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, PI3K/AKT/mTOR signaling in cancer, Fibroblast Growth Factor Research, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies
Most-Cited Works
- → FGFR3 mutations in prostate cancer: association with low-grade tumors(2009)74 cited
- → Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas(2010)69 cited
- → A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer(2012)67 cited
- → Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer(2012)63 cited
- → Benefits of using a hybrid problem-based learning curriculum to improve long-term learning acquisition in undergraduate biology education(2016)60 cited
- → PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events(2010)51 cited
- → KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations(2008)44 cited
- → Using Role Play to Debate Animal Testing(2014)43 cited
- → ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression(2017)23 cited
- → CXCR4 mRNA overexpression in high grade prostate tumors: Lack of association with TMPRSS2-ERG rearrangement(2013)13 cited